SCHEMBL6203911

SCHEMBL6203911

COC(O)Cc1c(F)cccc1F

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.36
GAA P10253 2/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP12 P39900 1/20 0.35
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 3/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
KCNH2 Q12809 1/20 0.34
KMT2A Q03164 2/20 0.33
TAAR1 Q96RJ0 1/20 0.33
MEN1 O00255 1/20 0.33
DPP4 P27487 1/20 0.33
MAPK1 P28482 1/20 0.33
CES2 O00748 2/20 0.33
CES1 P23141 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6201421 0.78 IDO1 (0.42) ALDH1A1KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL9729259 0.78 SMN1; SMN2 (0.35) SMN1; SMN2GAAALDH1A1KDM4ESLC6A2
SCHEMBL2422907 0.77 GAA (0.38) SMN1; SMN2GAAALDH1A1KDM4ESLC6A2
SCHEMBL6203907 0.76 SMN1; SMN2 (0.36) SMN1; SMN2GAAALDH1A1KDM4ESLC6A2
SCHEMBL6204367 0.76 AKR1B1 (0.39) SMN1; SMN2GAAALDH1A1KDM4ESLC6A2
SCHEMBL25440547 0.74
SCHEMBL6204388 0.72 SLC1A1 (0.46) TAAR1
SCHEMBL170907 0.72 GABRA1 (0.43) SMN1; SMN2GAAALDH1A1KDM4ESLC6A2
SCHEMBL10058270 0.71 GAA (0.37) SMN1; SMN2GAAALDH1A1KDM4EKMT2A
SCHEMBL6205902 0.69 TRPA1 (0.50) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed